We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Celadon Pharmaceuticals Plc | LSE:SWC | London | Ordinary Share | Ordinary Shares |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 147.50 | 140.00 | 155.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMSWC
RNS Number : 5095Q
Summerway Capital PLC
26 February 2021
26 February 2021
Summerway Capital Plc
("Summerway" or the "Company")
Result of Annual General Meeting
Following the Annual General Meeting of the Company, which was held earlier today, the Board is pleased to announce that all the ordinary and special resolutions set out in the Notice of General Meeting were duly passed.
Full details of the resolutions passed are set out in the Notice of General Meeting which is available on the Company's website at www.summerwaycapital.co.uk.
Ordinary Resolutions Total votes For Against cast Abstain % % % ----------------------------- ------------ ---------- ------ ---- ----- ----- ----- 1 Presentation of the Accounts 3,390,166 3,390,166 100 0 0 0 0 ----------------------------- ------------ ---------- ------ ---- ----- ----- ----- To elect Vinodka Murria 2. OBE as a Director 3,390,166 3,390,166 100 0 0 0 0 ----------------------------- ------------ ---------- ------ ---- ----- ----- ----- To elect Paul Gibson 3. as a Director 3,390,166 3,390,166 100 0 0 0 0 ----------------------------- ------------ ---------- ------ ---- ----- ----- ----- To elect Anthony Morris 4. as a Director 3,390,166 3,390,166 100 0 0 0 0 ----------------------------- ------------ ---------- ------ ---- ----- ----- ----- To re-elect Benjamin 5. Shaw as a Director 3,390,166 3,389,588 99.98 578 0.02 0 0 ----------------------------- ------------ ---------- ------ ---- ----- ----- ----- To re-elect David Firth 6. as a Director 3,390,166 3,389,588 99.98 578 0.02 0 0 ----------------------------- ------------ ---------- ------ ---- ----- ----- ----- To re-appoint the auditors, 7. RSM UK Audit LLP 3,390,166 3,390,166 100 0 0 0 0 ----------------------------- ------------ ---------- ------ ---- ----- ----- ----- To authorise the Directors to set the auditors' 8. remuneration 3,390,166 3,390,166 100 0 0 0 0 ----------------------------- ------------ ---------- ------ ---- ----- ----- ----- To authorise the allotment 9. of Shares 3,390,166 3,389,491 99.98 675 0.02 0 0 ----------------------------- ------------ ---------- ------ ---- ----- ----- ----- To approve the Company's 10. investment policy 3,390,166 3,390,166 100 0 0 0 0 ----------------------------- ------------ ---------- ------ ---- ----- ----- ----- Special Resolution ------------ ---------- ------ ---- ----- ----- ----- To disapply pre-emption 11. rights 3,390,166 3,390,166 100 0 0 0 0 ----------------------------- ------------ ---------- ------ ---- ----- ----- -----
As at the date of the AGM, the number of issued shares and total voting rights of the Company was 8,033,409 shares in issue. The Company's Articles of Association set out that every member who is present in person or by proxy shall have one vote for every share of which he is the holder on a poll.
Enquiries:
Summerway Capital Plc
Tony Morris (Director) +44 (0) 20 7440 7520
N+1 Singer (Nominated Adviser and Broker)
Sandy Fraser, Amanda Grey +44 (0) 20 7496 3000
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
RAGEAEAKASKFEFA
(END) Dow Jones Newswires
February 26, 2021 05:57 ET (10:57 GMT)
1 Year Celadon Pharmaceuticals Chart |
1 Month Celadon Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions